Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (13661)	5/25/2000 8:16:00 AM
From: ballydog1	Read Replies (2) \| Respond to of 17367

Blue, Thanks for the posting of articles. Will try and keep any resentment of Fed to a minimum. I was more in favor of raising margin requirements v. interest rates. No prejudice against investing at all levels, provided the subject company is a proven entity. Xoma has yet to demonstrate the characteristics of a Merck or Amgen. Waiting for the data. So the baboons infused with E. coli & given rBPI21 were in much better shape after 2 hrs. according to the study. And you're also implying that the fear of antibiotic treatment for gastrointestinal disorders is holding back FDA approval/acceptance of a BLA for BPI ? BTW the BBH & BTK (and Nazzdog) bounced yesterday at or near the lowest levels since Nov/Dec/Jan.

To: Bluegreen who wrote (13661)	5/25/2000 11:15:00 AM
From: Cacaito	Read Replies (2) \| Respond to of 17367

Bluegreen, E.Coli 0157 could not be control by bpi, the mild and moderate cases do not need anything but oral or IV rehydration, peptobismol is as good (and probably better) than any antibiotic. The main problem is Acute Hemolytic Uremic Syndrome(HUS), reports keep coming to this thread over the years, same as the West coast hamburger (Jack in the box?)and juice companies related cases, HUS is an EXOTOXIN, not endotoxins which are the bpi target. Most of the time bacteria never reach the bloodstream, the EXOTOXIN does. Even peptobismol could beat a problem that xometimes bpi could not.